play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
volume_up
chevron_left

Featured

Blood Products

Dr Swapnil Pawar April 11, 2024 51


Background
share close
  • cover play_arrow

    Blood Products
    Dr Swapnil Pawar

Blood Products

Written by Dr Andrew Lam

Blood Products and Haemorrhagic Shock

 

PRBC’s

Isolated from whole blood through centrifuge

 

Transfusion should be individual based. But generally:

  1.  Hb <70
  2. Concurrent cardiovascular disease + Hb <80

 

FFP

Contains all coagulation factors – primarily 2, 7, 9 and 10

Dose: 15ml/kg

 

Indicated in:

  • Bleeding with associated factor deficiencies
  • Warfarin reversal  
  • DIC

 

Platelets

Separated from whole blood – often pooled from multiple blood donations

 

Transfuse if:

PLT < 10
PLT < 20 with risk factors
PLT < 50 for most surgical procedures or acutely bleeding
PLT < 100 for neurosurgical procedure

 

Cryoprecipitate

Derived from plasma – contains concentrated amount of von-willebrand factor, fibrinogen and Factors 8 and 11

 

Usually used in patients with fibrinogen or VWf deficiencies

Generally aim for fibrinogen > 1 at least

 

Massive Transfusion

Defined as replacement of either:

  • Full blood volume in 24 hours
  • >50% of blood volume in 4 hours

 

Each facility will have their own protocol for massive transfusion, but contains varying combinations of PRBC’s, FFP, platelets and Cryoprecipitate

 

Consequences of massive transfusion can include:

  • Fluid overload 
  • Hypothermia
  • Hyperkalemia
  • Lactic acidosis 
  • Hypocalcemia
Rate it
Previous episode
Thromboprophylaxis in COVID-19
Medspresso Podcast
play_arrow
share playlist_add
close
  • 42

Featured

DVT Prophylaxis

Dr Swapnil Pawar March 11, 2024

play_arrow DVT Prophylaxis Dr Swapnil Pawar VTE Prophylaxis Written by Dr Ashly Liu Venous thromboembolism risk As a junior medical officer, one of your responsibilities is to ensure all your […]

Read more trending_flat

Similar posts